Evotec SE (EVO) Invested Capital (2009 - 2026)
Evotec SE (EVO) reported Invested Capital of $103745.6 for Q1 2026, up 61.89% on a YoY basis from $64082.9 in Q1 2025, and down 99.98% sequentially from $599.7 million in Q4 2025.
Evotec SE (EVO) Invested Capital (2009 - 2026) Analysis & Trends
Evotec SE (EVO) has 9 years of Invested Capital data on file, last reported at $103745.6 in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital rose 61.89% year-over-year to $103745.6; the trailing twelve-month figure through Mar 2026 stood at $600.1 million (up 5.8% YoY), and the FY2025 full-year result was $599.7 million, up 5.76% from the prior year.
- Invested Capital eased to $103745.6 in Q1 2026, from $599.7 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $960.7 million in Q4 2022 to a low of -$1860.9 in Q2 2022.
- A 5-year average of $245.7 million and a median of $108497.7 in 2025 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital jumped 76038.53% in 2022 and tumbled 30.87% in 2024, its largest moves.
- Tracing EVO's Invested Capital over 5 years: stood at $960.7 million in 2022, then slipped by 14.62% to $820.3 million in 2023, then plunged by 30.87% to $567.1 million in 2024, then increased by 5.76% to $599.7 million in 2025, then slumped by 99.98% to $103745.6 in 2026.
- Business Quant data shows EVO's Invested Capital at $103745.6 in Q1 2026, $599.7 million in Q4 2025, and $113249.9 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | 103,745.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103,745.63 |
| Dec 31, 2025 | 599.72 Mn |
| Sep 30, 2025 | 113,249.87 |
| Jun 30, 2025 | 120,963.48 |
| Mar 31, 2025 | 64,082.90 |
| Dec 31, 2024 | 567.06 Mn |
| Sep 30, 2024 | 58,795.38 |
| Dec 31, 2023 | 820.31 Mn |
| Dec 31, 2022 | 960.72 Mn |
| Sep 30, 2022 | 38,822.59 |
| Jun 30, 2022 | -1,860.95 |
| Mar 31, 2022 | 40,566.90 |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 41,275.06 |
| Dec 31, 2020 | -394.67 Mn |
| Sep 30, 2010 | 254.38 |
| Jun 30, 2010 | 362.05 |
| Mar 31, 2010 | 653.58 |
| Dec 31, 2009 | 716.22 |
| Jun 30, 2009 | 818,350.63 |